BAL modulates glutamate transport in synaptosomes and synaptic vesicles from rat brain

Neuroreport. 2001 Mar 5;12(3):511-4. doi: 10.1097/00001756-200103050-00017.

Abstract

The therapeutic use of BAL (2,3-dimercaptopropanol) as treatment for poisoning has been halted by data suggesting serious neurotoxicity. This article is a report on the effects of BAL and other dithiols, DMSA (meso-2,3-dimercaptosuccinic acid) and DMPS (2,3-dimercaptopropane-1-sulfonic acid), on [3H]glutamate release and uptake by rat brain synaptosomes and [3H]glutamate uptake by synaptic vesicles. BAL (100 microM) inhibited glutamate uptake (30%) and stimulated its basal release (30%) in synaptosomes, without affecting K+-stimulated release. BAL also inhibited glutamate uptake by synaptic vesicles (up to 60%). DMPS and DMSA (100 microM) had no significant effects on these parameters. The data reported here provide some evidence of glutamate involvement in BAL-induced neurotoxicity by demonstrating direct effects of BAL on glutamatergic system modulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport / drug effects
  • Brain / metabolism
  • Chelating Agents / toxicity*
  • Dimercaprol / toxicity*
  • Glutamic Acid / pharmacokinetics*
  • In Vitro Techniques
  • Male
  • Potassium / pharmacology
  • Rats
  • Rats, Wistar
  • Succimer / toxicity
  • Synaptosomes / drug effects*
  • Synaptosomes / metabolism*
  • Tritium
  • Unithiol / toxicity

Substances

  • Chelating Agents
  • Dimercaprol
  • Tritium
  • Glutamic Acid
  • Unithiol
  • Succimer
  • Potassium